Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancer

Biochemical and Biophysical Research Communications

Volumn 393, Issue 3, 2010, Pages 555-559

  Murugan, Avaniyapuram Kannan ^a   Bojdani, Ermal ^a   Xing, Mingzhao ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anaplastic thyroid cancer; Follicular thyroid cancer; Genetics; IDH1 mutation; Isocitrate dehydrogenase; Thyroid cancer

Indexed keywords

GENOMIC DNA; ISOCITRATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE ISOENZYME; UNCLASSIFIED DRUG;

ANAPLASTIC CARCINOMA; ARTICLE; CANCER CELL CULTURE; CODON; CONTROLLED STUDY; DISEASE COURSE; DNA SEQUENCE; ENZYME ACTIVITY; EXON; FOLLICULAR CARCINOMA; GENE MUTATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS; THYROID CANCER;

AMINO ACID SEQUENCE; CELL TRANSFORMATION, NEOPLASTIC; DNA MUTATIONAL ANALYSIS; HUMANS; ISOCITRATE DEHYDROGENASE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; THYROID NEOPLASMS;

EID: 77949262337     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.02.095     Document Type: Article

References (15)

1. Parsons D.W., Jones S., Zhang X., Lin J.C., Leary R.J., Angenendt P., Mankoo P., Carter H., Kamiyama H., Jimeno A., Hong S.M., Fu B., Lin M.T., et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321 (2008) 1807-1812
2. Balss J., Meyer J., Mueller W., Korshunov A., Hartmann C., and von Deimling A. Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol. 116 (2008) 597-602
3. Yan H., Parsons D.W., Jin G., McLendon R., Rasheed B.A., Yuan W., Kos I., Batinic-Haberle I., Jones S., Riggins G.J., Friedman H., Friedman A., Reardon D., Herndon J., Kinzler K.W., Velculescu V.E., Vogelstein B., and Bigner D.D. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360 (2009) 765-773
4. Bleeker F.E., Lamba S., Leenstra S., Troost D., Hulsebos T., Vandertop W.P., Frattini M., Molinari F., Knowles M., Cerrato A., Rodolfo M., Scarpa A., Felicioni L., Buttitta F., Malatesta S., Marchetti A., and Bardelli A. IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. Hum. Mutat. 30 (2009) 7-11
5. Geisbrecht B.V., and Gould S.J. The human PICD gene encodes a cytoplasmic and peroxisomal NADP (+)-dependent isocitrate dehydrogenase. J. Biol. Chem. 274 (1999) 30527-30533
6. Mardis E.R., Ding L., Dooling D.J., Larson D.E., McLellan M.D., Chen K., Koboldt D.C., Fulton R.S., Delehaunty K.D., McGrath S.D., Fulton L.A., Locke D.P., et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361 (2009) 1058-1066
7. Kang M.R., Kim M.S., Oh J.E., Kim Y.R., Song S.Y., Seo S.I., Lee J.Y., Yoo N.J., and Lee S.H. Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. Int. J. Cancer 125 (2009) 353-355
8. Xu X., Zhao J., Xu Z., Peng B., Huang Q., Arnold E., and Ding J. Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self regulatory mechanism of activity. J. Biol. Chem. 279 (2004) 33946-33957
9. Zhao S., Lin Y., Xu W., Jiang W., Zha Z., Wang P., Yu W., Li Z., Gong L., Peng Y., Ding J., Lei Q., Guan K.L., and Xiong Y. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF1alpha. Science 324 (2009) 261-265
10. Ichimura K., Pearson D.M., Kocialkowski S., Bäcklund L.M., Chan R., Jones D.T., and Collins V.P. IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas. Neuro-oncol. 11 (2009) 341-347
11. Neff R.L., Farrar W.B., Kloos R.T., and Burman K.D. Anaplastic thyroid cancer. Endocrinol. Metab. Clin. North Am. 37 (2008) 525-538
12. Murugan A.K., Dong J., Xie J., and Xing M. MEK1 mutations, but not ERK2 mutations, occur in melanomas and colon carcinomas, but none in thyroid carcinomas. Cell Cycle 8 (2009) 2122-2124
13. Murugan A.K., Hong N.T., Fukui Y., Munirajan A.K., and Tsuchida N. Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas. Int. J. Oncol. 32 (2008) 101-111
14. Steen I.H., Lien T., and Birkeland N.K. Biochemical and phylogenetic characterization of isocitrate dehydrogenase from a hyperthermophilic archaeon, Archaeoglobus fulgidus. Arch. Microbiol. 168 (1997) 412-420
15. +-specific isocitrate dehydrogenase. Biochemistry 36 (1997) 13743-13747